Healthcare & Life Sciences

Ancilia Therapeutics

United States

seed

Stage

Investors

About

Ancilia Therapeutics develops a computational therapeutic platform focused on microbiome-related diseases, utilizing computational methods to discover or design microbiome-targeted therapies.

Explore Ancilia Therapeutics's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.